CD79A and myeloid sarcoma: Our investigation on immunological response to ETX by Western blotting and quantitative ELISA shows a high prevalence of anti-ETX antibodies, predominantly IgM over IgG and IgA, in the sera of one hundred MS patients as well as in ninety healthy controls.